News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Vivek Subbiah: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
Vivek Subbiah/LinkedIn
Feb 3, 2025, 14:01

Vivek Subbiah: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted on X about recent paper by Jia Liu et al., titled “Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials” published on Journal of Clinical Oncology.

Authors: Jia Liu, Max Farrow, Lesley Seymour, Jayesh Desai, Herbert H. Loong, Percy Ivy, Takafumi Koyoma, Natalie Cook, Sarah Blagden, Elena Garralda, Christophe Massard, Anthony W. Tolcher, Jacob J. Adashek, Li Zhang, Shen Zhao, Lin Shen, Razelle Kurzrock, Wafik S. El-Deiry, Vivek Subbiah, Anthony M. Joshua.

Vivek Subbiah: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials

“Nice overview in JCO Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials. Terrific work by

Anthony M Joshua Herbert H. Loong Jayesh Desai JCO Jia Liu Lesley Seymour Max Farrow Percy Ivy Takafumi Koyoma Vivek Subbiah Wafik S. El-Deiry
Special Coverage
Opinion
Feb 3, 2025, 14:07
Daniel Heng: Treatment free survival is becoming an important endpoint in different mRCC treatments
Blog
Feb 3, 2025, 14:07
Elisa Agostinetto: The results of our translational research project on lobular breast cancer at BSMO25
Blog
Feb 3, 2025, 14:01
Vivek Subbiah: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials
Blog
Feb 3, 2025, 13:59
Talha Badar: Quick overview on Ph-like Acute Lymphoblastic Leukemia
Blog
Feb 3, 2025, 13:57
Ezra Cohen: Benefit of adding cetuximab adjuvantly was seen only in HPV negative cancers
Blog
Feb 3, 2025, 13:54
Register to attend the EHA-EBMT 7th European CAR T-cell Meeting
Blog
Feb 3, 2025, 13:51
4 questions for mathematical oncologist Heiko Enderling - MD Anderson Cancer Center
Blog
Feb 3, 2025, 13:46
Özcan Met: The first patient with melanoma received TILs edited with non-viral CRISPR technology
Blog
Feb 3, 2025, 13:44
Nelson Moss: CNS metastases are the main challenge in HER2+ breast cancer
Insight
Feb 3, 2025, 13:12
Supriya Peshin: Bosutinib-induced pleural effusion - class effect and cross-intolerance to all TKIs
Opinion
Feb 3, 2025, 13:10
Gustavo Viani: Does acute toxicity predict late toxicity in prostate radiotherapy?
Blog
Feb 3, 2025, 13:06
Stephen V Liu: Grateful for the chance to learn from the top lung cancer experts at ITCD2025